On March 6, 2024, Caligan Partners LP announced that it has submitted to Anika Therapeutics, Inc. a notice of its intention to nominate 2 individuals, David Johnson and William Jellison, for election to the Board in connection with the Company?s 2024 annual meeting of stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.79 USD | -1.71% | +0.55% | +13.81% |
May. 30 | Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics | CI |
May. 28 | Anika Therapeutics Approves $40 Million Share Repurchase Program | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.81% | 389M | |
+0.82% | 93.19B | |
-1.32% | 39.62B | |
-12.88% | 33.78B | |
+64.77% | 26.82B | |
-16.31% | 15.35B | |
-5.78% | 13.13B | |
-11.38% | 11.6B | |
-49.84% | 10.26B | |
+5.24% | 9.43B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Caligan Partners LP Issues Notice of Nominations to Anika Therapeutics, Inc